Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Treatment.com International ( (TSE:TRUE) ) just unveiled an announcement.
Treatment.com AI’s subsidiary, Rocket Doctor, in partnership with EngageWell IPA and backed by CVS Health Foundation, has launched the Healthy Aging Program in New York City. This initiative provides free virtual health screenings for adults over 60, aiming to support their health and independence. The program, funded by a $1 million grant, offers assessments for heart health, memory, and mental well-being, with consultations conducted by board-certified physicians. It addresses healthcare access issues for older adults, especially those facing language barriers or low digital literacy, by combining technology and community support to create a dignified and culturally relevant care model.
Spark’s Take on TSE:TRUE Stock
According to Spark, TipRanks’ AI Analyst, TSE:TRUE is a Underperform.
Treatment.com International is struggling financially, with persistent losses and negative cash flow overshadowing recent revenue growth. The stock is technically weak, and valuation metrics highlight its unprofitable status. However, recent corporate events, including strategic acquisitions and partnerships, provide some potential for future growth, although they have not yet addressed the core financial challenges.
To see Spark’s full report on TSE:TRUE stock, click here.
More about Treatment.com International
Treatment.com AI is a company utilizing artificial intelligence and clinical practices to enhance the healthcare sector, addressing inefficiencies and challenges. Rocket Doctor, a subsidiary, is a digital health platform that enables doctors to manage virtual or hybrid practices, focusing on underserved communities. EngageWell IPA, formed by New York City non-profits, offers integrated treatment options addressing social determinants of health.
Average Trading Volume: 136,473
Technical Sentiment Signal: Sell
Current Market Cap: C$30.2M
For an in-depth examination of TRUE stock, go to TipRanks’ Overview page.